Introduction Up to 50% of patients surviving a pulmonary embolism (PE) report persisting
shortness of breath, reduced physical capacity and psychological distress. As the PE …

Background Cystatin C is a novel biomarker to identify renal dysfunction and cardiovascular
risk. Objective The aim of this study was to investigate the role of cystatin C in non-invasive …

Chronic thromboembolic pulmonary disease results from the incomplete resolution of
thrombi, leading to fibrotic obstructions. These vascular obstructions and additional …

Background and Objectives: The aim of this study was to evaluate the effectiveness and
safety of balloon pulmonary angioplasty (BPA) in patients with inoperable chronic …

Background and Objectives: Chronic thromboembolic pulmonary hypertension (CTEPH) is a
chronic progressive disease, resulting from persistent arterial obstruction combined with …

Background The long-term exercise tolerance changes in patients with nontuberculous
mycobacterial pulmonary disease (NTM-PD) are of great interest because of its chronic …

Background Adaptive immunity is an important disease mediator of pulmonary vascular
remodeling during pulmonary hypertension (PH) development, especially T-cells …

This paper presents a technology for applying copper and silver films to cotton fabrics by
combining photochemical and chemical methods for the reduction of the compounds of …

Background Assessment of the pattern of the RV outflow tract Doppler provides insights into
the hemodynamics of chronic thromboembolic pulmonary hypertension (CTEPH). We …

Background: Computed tomography (CT) of the aorta and cardiac vessels, which is
performed in patients with severe aortic valve stenosis (AS) before transcatheter aortic valve …